{
  "docId": "019dd923-622c-750b-8b9a-4b91788fc785",
  "docSlug": "5fadb686cc03",
  "documentTitle": "Twist Bioscience (TWST)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2022-11-15 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.2941177,
  "pageNumber": 157,
  "pageCount": 236,
  "prevPage": 156,
  "nextPage": 158,
  "slideType": "villain_critique",
  "function": "expose_contradiction",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "The slide uses a Q&A format to highlight reputational risks and quality concerns regarding Twist Bioscience.",
  "elementsJson": [
    "paragraph",
    "quote_block",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-4b91788fc785/157",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-4b91788fc785",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-4b91788fc785.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-4b91788fc785#slide-157",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Twist 'scares the living heck out of anyone in the clinical space' who would be 'scared to death' of being 'censured by the FDA' for using an 'inconsistent panel.'",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-0932-77cf-bff1-18444d88b71b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.9,
        "x": 0.05,
        "y": 0.5
      },
      "kind": "paragraph",
      "text": "A: “When you see marketing material, especially for a highly technical audience that doesn't have things like legends or scales, you might get a little bit skeptical. And they produce a lot of that kind of marketing material. That's your first hint. I have seen Twist marketing material that shows stuff like on-target percentages for - this is getting into the weeds of next-gen sequencing, but they will display data for different quality metrics that researchers will use to judge the effectiveness of a next-generation sequencing lockdown panel, hybridization capture panel. But they won't do scales or legends consistently, which makes you think that's weird. Any scientist is going to be like, if you were a graduate student and you presented that to your research professor, they'd be like, you're an idiot. Why are you here? You don't do that.”",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2ba56f5b-2219-427d-9b96-195d9e9ea495",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.9,
        "x": 0.05,
        "y": 0.12
      },
      "kind": "paragraph",
      "text": "We found his knowledge of Twist's product line, manufacturing process, and competitive positioning to be detailed. He stated that the “emperor has no clothes\" - a reputation in the market for low-quality sequences with consistency problems; misleading marketing that would get a grad student called out; and that Twist “scares the living heck out of anyone in the clinical space” who would be “scared to death” of being “censured by the FDA” for using an “inconsistent panel.”",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4b680e41-9702-4e94-8db9-9a66203e2b0d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.78
      },
      "kind": "paragraph",
      "text": "A: “Yeah, yeah. I think that is how they're perceived in the market. Actually, I don't think. I know that's how they're perceived in the market. Depending on your application, you might not care. But yeah, they have a quality and more importantly, especially for regulated spaces like oncology sequencing, they have a consistency problem. The consistency problem is what scares the living heck out of anyone in a clinical space because the last thing that those lab directors want is the FDA to be knocking on their doors and be like, show me the variants of your results. And they're scared to death that because they used an inconsistent panel, they're going to get censured by the FDA.” -IDT ex-regional sales manager, left recently",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "623ac962-e1f3-4fa9-903a-8e54bc0ab2dc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.9,
        "x": 0.05,
        "y": 0.7
      },
      "kind": "paragraph",
      "text": "Q: “Are you saying their products are fairly inferior? You said they got the price-sensitive, less quality-sensitive customer that you described as a cut above McDonald's. So, their genes, NGS, oligo pools, the fact that they aren't using legends - are you essentially saying that their stuff isn't as high quality? Is that how they're perceived in the market?”",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7759c92b-6fb5-484f-bf76-f95c6ce9ba5d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.45
      },
      "kind": "paragraph",
      "text": "Misleading marketing; reputation in the market for low-quality sequences with consistency problems; “scares the living heck out of anyone in a clinical space” who would be “scared to death” of being “censured by the FDA” for using an “inconsistent panel”",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "beefe3aa-094c-46de-a576-2e371231b15f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "“When you see marketing material, especially for a highly technical audience that doesn't have things like legends or scales, you might get a little bit skeptical... Any scientist is going to be like, if you were a graduate student and you presented that to your research professor, they'd be like, you're an idiot. Why are you here? You don't that.” — IDT ex-regional sales manager",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-0932-77cf-bff1-1e4d41afbb40",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.3,
        "x": 0.05,
        "y": 0.96
      },
      "kind": "source-note",
      "text": "Source: Scorpion Capital consultation calls with experts",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ae92c354-9193-46bc-b112-f1082ece18f2",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}